Free Republic 2nd Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $54,770
Woo hoo!! And we're now over 62%!! Thank you all very much for your continuing support!

Keyword: nejm

Brevity: Headers | « Text »
  • Weight loss does not lower heart disease risk, says 11-year study

    06/27/2013 10:23:20 PM PDT · by Jyotishi · 40 replies
    DNA ^ | Tuesday, June 25, 2013 | ANI
    Adults with diabetes can begin to realize many of these health benefits with even modest reductions in body weight and modest increases in physical activity. People undergoing weight management and increased physical activity have no difference in heart attacks and strokes, a new study has suggested. The landmark study investigating the long-term effects of weight loss on the risks of cardiovascular disease among patients with Type 2 diabetes, which was conducted at the University of Pittsburgh and at clinical facilities throughout the United States, the multicenter clinical trial investigated the effects of an intensive lifestyle intervention program, intended to achieve...
  • Medical Journal Bias on Guns

    10/18/2010 1:37:37 PM PDT · by JohnRLott · 30 replies · 2+ views
    National Review Online ^ | October 18, 2010 | John R. Lott Jr.
    Medical journals are not always the objective, purely scientific publications we might think that they are. Their editors have increasingly strayed into politics at the expense of scientific accuracy. For example, the prestigious New England Journal of Medicine has over the last few months published a number of extremely biased and poorly done studies on gun control. One of the articles, written by Garen Wintemute, Anthony Braga, and David Kennedy, makes the case for extending background checks to the private transfers of guns, arguing that “perhaps the principal reason for the well-documented failure of the Brady Act to lower rates...
  • Most Readers Find Gun Control Outside Realm of Public Health

    07/23/2008 10:59:36 AM PDT · by marktwain · 16 replies · 126+ views
    Medpage Today ^ | 22 July, 2008 | Marianne Matteraing Managing Editor
    Gun regulation is not a public health issue, according to more than 80% of some 2,000 respondents to a MedPage Today poll. When the editors of the New England Journal of Medicine decried the recent Supreme Court decision overturning the District of Columbia's handgun law, they did so claiming the issue is a matter of public health. Now doctors in the trenches have weighed in with their own views. The responses from physicians who are registered members of the site was remarkbly evenly divided. Just over half (52%) said Yes, that gun control is a public health issue. But for...
  • Why the Data Diverge on the Dangers of Vioxx

    05/22/2006 1:39:51 PM PDT · by neverdem · 19 replies · 694+ views
    NY Times ^ | May 22, 2006 | ANDREW POLLACK and REED ABELSON
    Eighteen months. Ever since Merck pulled its arthritis painkiller Vioxx off the market in September 2004 on evidence that it could cause strokes or heart attacks, the company and its lawyers have stood by the premise that it was dangerous only to patients who took it for at least 18 months. So it was news last week when prominent medical experts said that new data from Merck indicated that Vioxx's risks started to emerge after only four months of use. The controversy is the latest illustration of how widely open to interpretation and potential corporate pressure the results of clinical...
  • Treatment Is Seen to Cut Breast Cancer Recurrence

    03/10/2004 11:13:41 PM PST · by neverdem · 7 replies · 443+ views
    NY Times ^ | March 11, 2004 | ANAHAD O'CONNOR
    Drugs that completely block estrogen can lower the risk of breast cancer recurrence in postmenopausal women after surgery, according to the latest study to suggest that some women can improve their chances of recovering from breast cancer with aromatase inhibitors. The study followed more than 4,700 women who took tamoxifen, the most common treatment for preventing recurrences of breast cancer. But women who switched to the estrogen-blocker exemestane two and a half years later cut their chances of developing another tumor by a third. Taking exemestane, which is sold under the brand name aromasin by Pfizer, also provided better protection...
  • Deadly Lung Condition Found in Many Sickle-Cell Patients

    02/26/2004 1:46:13 PM PST · by neverdem · 9 replies · 297+ views
    NY Times ^ | February 26, 2004 | WARREN E. LEARY
    WASHINGTON, Feb. 25 — High blood pressure in the lungs has been identified as a major risk factor for death in adults with sickle-cell disease, and all people with the disease should be screened for this complication, according to a study being published Thursday. Almost one-third of adult sickle-cell patients who were screened with a noninvasive ultrasound method were found to have moderate to severe pulmonary hypertension and high blood pressure in the lungs that had not previously been detected, the study found. The results from the tests confirm earlier suggestions from studies of patient records that pulmonary hypertension is...
  • Business, Science Clash at Medical Journal

    02/07/2004 5:34:47 PM PST · by neverdem · 4 replies · 144+ views
    The Washington Post ^ | February 7, 2004 | Shankar Vedantam
    Business, Science Clash at Medical Journal An analysis critical of the growing use of an expensive medicine used for dialysis patients was turned down by the most widely circulated medical journal in the field after its marketing department objected, according to an e-mail from the journal's editor to the article's author. Three senior scientists had reviewed the analysis and approved it for publication, Joseph Herman, executive editor of Dialysis & Transplantation, wrote to author Dennis Cotter, president of a nonprofit health research group in Bethesda. "Unfortunately, I have been overruled by our marketing department with regard to publishing the editorial,"...